StonvexLoading…
StonvexStonvexStonvexCore line items from ARE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.03B | $3.12B | $2.89B | $2.59B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $-1.43B | $322.95M | $103.64M | $521.66M |
EPS (Diluted) | $-8.44 | $1.80 | $0.54 | $3.18 |
Total Assets | $34.08B | $37.53B | $36.77B | $35.52B |
Total Liabilities | $14.93B | $15.13B | $14.15B | $12.84B |
Cash & Equivalents | $549.06M | $552.15M | $618.19M | $825.19M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 170.54M | 172.20M | 171.91M | 170.75M |